Diagnose Disease Radiopharmaceuticals 
AuntMinnie
JULY 26, 2024
Evidence showed that Sheriff owned and was pharmacist in charge at Shertech, a pharmacy that provided nuclear and radiopharmaceutical drugs to medical facilities. The resulting diluted product was used in procedures such as renal scans to diagnose various illnesses, such as kidney disease.
AuntMinnie
JULY 10, 2024
Centers for Medicare and Medicaid Services (CMS) proposed a new reimbursement plan July 10 for diagnostic PET scans that would provide separate payments for radiopharmaceuticals, as well as an extra payment for hospitals when they use domestically produced technetium-99m (Tc-99m).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
AuntMinnie
DECEMBER 8, 2023
Suspicion of malignancy may be prompted by avid uptake of the radiopharmaceutical FDG on PET/CT imaging, according to study results delivered on November 27 at the RSNA meeting. Pulmonary metastases were found in five of the 10 (50%) and primary lung cancers in the other five (50%).
AuntMinnie
FEBRUARY 12, 2024
Chinese clinicians have provided evidence in a “real-world study” that shows amyloid PET imaging is effective for diagnosing and managing patients with Alzheimer’s disease, according to a study published February 8 in Alzheimer’s and Dementia. of patients, noted lead author Ke-Liang Chen, MD, a neurologist at Fudan University.
AuntMinnie
MARCH 25, 2024
Coronary artery disease (CAD) is the leading cause of mortality in the U.S. In a cohort of 1,282 patients who underwent invasive coronary angiography for suspected disease, noninvasive PET MPI performed within six months identified large perfusion defects (>10% of the left ventricular myocardium) in 82% of the patients.
Imaging Technology
OCTOBER 17, 2023
a clinical stage radiopharmaceutical company focused on the discovery and development of novel agents for the treatment of a wide range of oncology indications, is pleased to announce that the first subject has been dosed in its Phase 1 study of 68Ga-R8760. milla1cf Tue, 10/17/2023 - 13:07 October 17, 2023 — Radionetics Oncology, Inc.,
AuntMinnie
JANUARY 30, 2024
The timing of the new codes dovetails with advances in neuroimaging, such as in the assessment of white-matter diseases. A widely used class of radiopharmaceuticals in the study of the neuroinflammatory response targets the translocator protein (TSPO), according to the researchers.
Expert insights. Personalized for you.
246 
Let's personalize your content